Clinical and Patient-Reported Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

被引：1
|
作者：
Ionova, Tatyana I. [1 ]
Nikitina, Tatiana P. [1 ]
Gritsenko, Taras A. [2 ]
Ivanova, Valentina L. [3 ]
Kuchma, Galina B. [4 ]
Shnaider, Tatyana V. [5 ]
Fedorenko, Denis A. [6 ]
Kurbatova, Kira A. [1 ]
Novik, Andrei A. [6 ]
机构：
[1] Multinatl Ctr Qual Life Res, St Petersburg, Russia
[2] Samara State Med Univ, Samara, Russia
[3] Botkin Municipal Clin Hosp, Moscow, Russia
[4] Orenburg State Med Acad, Orenburg, Russia
[5] St Petersburg Reg Hosp, St Petersburg, Russia
[6] Moscow Natl Pirogov Med Surg Ctr, Moscow, Russia
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4445.4445
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4445
引用
收藏
页数：2
相关论文
共 50 条
  • [1] DASATINIB TREATMENT OF IMATINIB-RESISTANT AND IMATINIB-INTOLERANT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN A CHRONIC PHASE
    Vinogradova, O. Yu.
    Turkina, A. G.
    Vorontsova, A. V.
    Chelysheva, E. Yu.
    Gusarova, G. A.
    Kuznetsov, S. V.
    Goryacheva, S. R.
    Sokolova, M. A.
    Abakumov, E. M.
    Stakhina, O. V.
    Domracheva, E. V.
    Misyurin, A. V.
    Khoroshko, N. D.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (07) : 41 - 46
  • [2] BENEFITS/RISKS OF DASATINIB THERAPY IN PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC MYELOID LEUKEMIA: PHYSICIAN'S AND PATIENT'S
    Ionova, T.
    Nikitina, T.
    Gritsenko, T.
    Ivanova, V.
    Kuchma, G.
    Shnaider, T.
    Sannikova, I.
    Fedorenko, D.
    Kurbatova, K.
    HAEMATOLOGICA, 2013, 98 : 559 - 559
  • [3] Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
    Cortes, J.
    Kim, D-W
    Raffoux, E.
    Martinelli, G.
    Ritchie, E.
    Roy, L.
    Coutre, S.
    Corm, S.
    Hamerschlak, N.
    Tang, J-L
    Hochhaus, A.
    Khoury, H. J.
    Bruemmendorf, T. H.
    Michallet, M.
    Rege-Cambrin, G.
    Gambacorti-Passerini, C.
    Radich, J. P.
    Ernst, T.
    Zhu, C.
    Van Tornout, J. M. A.
    Talpaz, M.
    LEUKEMIA, 2008, 22 (12) : 2176 - 2183
  • [4] Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
    J Cortes
    D-W Kim
    E Raffoux
    G Martinelli
    E Ritchie
    L Roy
    S Coutre
    S Corm
    N Hamerschlak
    J-L Tang
    A Hochhaus
    H J Khoury
    T H Brümmendorf
    M Michallet
    G Rege-Cambrin
    C Gambacorti-Passerini
    J P Radich
    T Ernst
    C Zhu
    J M A Van Tornout
    M Talpaz
    Leukemia, 2008, 22 : 2176 - 2183
  • [5] THE VALUE OF DASATINIB THERAPY IN PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC MYELOID LEUKEMIA FROM PHYSICIAN'S AND PATIENT'S PERSPECTIVE: "REAL WORLD" OUTCOMES
    Ionova, T.
    Nikitina, T.
    Gritsenko, T.
    Ivanova, V.
    Kuchma, G.
    Shnaider, T.
    Sannikova, I.
    Usacheva, E.
    Fedorenko, D.
    Kurbatova, K.
    HAEMATOLOGICA, 2014, 99 : 214 - 214
  • [6] Long-Term Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or - Intolerant Chronic Myeloid Leukemia from Physician's and Patient's Perspective
    Ionova, Tatyana I.
    Nikitina, Tatyana P.
    Fedorenko, Denis A.
    Gritsenko, Taras A.
    Ivanova, Valentina L.
    Kuchma, Galina B.
    Shnaider, Tatyana V.
    Sannikova, Inga V.
    Usacheva, Elena I.
    Kurbatova, Kira A.
    BLOOD, 2014, 124 (21)
  • [7] Outcomes of Second-Line Treatment By Dasatinib in Imatinib-Resistant or - Intolerant Chronic Myeloid Leukemia Patients with and without Comorbidities
    Ionova, Tatyana
    Nikitina, Tatyana
    Kuchma, Galina
    Lomaia, Elza
    Shnaider, Tatyana
    Usacheva, Elena
    Kurbatova, Kira
    BLOOD, 2015, 126 (23)
  • [8] Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Abbott, Brian L.
    CLINICAL THERAPEUTICS, 2012, 34 (02) : 272 - 281
  • [9] Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
    Hoyle, Martin
    Rogers, Gabriel
    Moxham, Tiffany
    Liu, Zulian
    Stein, Ken
    VALUE IN HEALTH, 2011, 14 (08) : 1057 - 1067
  • [10] USING OF DASATINIB FOR TREATMENT IMATINIB-RESISTANT AND IMATINIB-INTOLERANT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE. RUSSIAN EXPERIENCE OF DASATINIB TREATMENT
    Khoroshko, N.
    Vinogradova, O.
    Turkina, A.
    Voroncova, A.
    Chelysheva, E.
    Gusarova, G.
    Kuznetsov, S.
    Gorjacheva, S.
    Sokolova, M.
    Abakumov, E.
    Lazareva, O.
    Domracheva, E.
    Misyurin, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 539 - 539
12345